AstraZeneca's Rare Drug Trial Failure Sends Shares Plunging
BloombergDuration: 3:36
Read the full storyUp next
- Edward Jones' Andy Blocker on US Midterm Elections
- Host Hotels & Resorts CEO on 3Q Quarterly Results
- Economic Frustrations Flip GOP Strongholds Blue
- 248 Ventures' Bell on What Qualcomm's 4Q Mean for Tech
- ScottsMiracle-Gro CEO on Earnings Beat, Growth Outlook
- John Chambers Makes the Case for AI, Calling It a Win for Society
